These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 15053152)

  • 1. [Psychostimulants: a therapeutic alternative in thymic and obsessive compulsive disorders (second part)].
    Samain V
    Rev Med Brux; 2004 Feb; 25(1):29-39. PubMed ID: 15053152
    [No Abstract]   [Full Text] [Related]  

  • 2. [Psychostimulants: a potential therapeutic alternative in mood and obsessive compulsive disorders (first part)].
    Samain V
    Rev Med Brux; 2003 Dec; 24(6):464-9. PubMed ID: 14748179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of psychopharmacology in obsessive compulsive disorders.
    Sarwer-Foner GJ
    Psychiatr J Univ Ott; 1987 Nov; 12(4):197-202. PubMed ID: 3326003
    [No Abstract]   [Full Text] [Related]  

  • 4. Guidelines on psychotropic drugs for the EC. Clinical investigation of medicinal products in the treatment of generalized anxiety disorder, panic disorder and obsessive-compulsive disorder.
    Eur Neuropsychopharmacol; 1995 Jun; 5(2):151-5. PubMed ID: 7549458
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of obsessive-compulsive disorder. The Expert Consensus Panel for obsessive-compulsive disorder.
    J Clin Psychiatry; 1997; 58 Suppl 4():2-72. PubMed ID: 9183300
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacokinetic and pharmacodynamic drug interactions with polypharmacotherapy of treatment-resistant affective and obsessive-compulsive disorders.
    Carson SW
    Psychopharmacol Bull; 1996; 32(4):555-68. PubMed ID: 8993076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical management of obsessive-compulsive-bipolar comorbidity: a case series.
    Raja M; Azzoni A
    Bipolar Disord; 2004 Jun; 6(3):264-70. PubMed ID: 15117406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The obsessive-compulsive disorder. Pharmacotherapeutic and neurobiological aspects and the relation to affective pathology].
    Fornaro P
    Minerva Psichiatr; 1988; 29(2):95-103. PubMed ID: 3057306
    [No Abstract]   [Full Text] [Related]  

  • 9. Epidemiologic and clinical findings of significance to the design of neuropharmacologic studies of obsessive-compulsive disorder.
    Rasmussen SA; Tsuang MT
    Psychopharmacol Bull; 1986; 22(3):723-9. PubMed ID: 3797577
    [No Abstract]   [Full Text] [Related]  

  • 10. Naltrexone treatment of self-injurious behavior.
    Godart NT; Agman G; Perdereau F; Jeammet P
    J Am Acad Child Adolesc Psychiatry; 2000 Sep; 39(9):1076-8. PubMed ID: 10986803
    [No Abstract]   [Full Text] [Related]  

  • 11. On the selection and use of atypical antipsychotics in the management of nonpsychotic mood and anxiety disorders.
    Blier P
    J Psychiatry Neurosci; 2005 Jul; 30(4):304. PubMed ID: 16049572
    [No Abstract]   [Full Text] [Related]  

  • 12. Efficacy of major psychotropic medications: critical role for psychiatric nursing.
    Fox J
    ANA Publ; 1994 May; (PMH-13 10 M):56-8. PubMed ID: 8048766
    [No Abstract]   [Full Text] [Related]  

  • 13. When pills make sense. Some parents turn too quickly to mood-altering drugs. But often medication is the right choice.
    Sachs A
    Time; 2000 Mar; 155(11):F12. PubMed ID: 11009701
    [No Abstract]   [Full Text] [Related]  

  • 14. Psychocutaneous drug therapy.
    Lee CS; Koo J
    Semin Cutan Med Surg; 2003 Sep; 22(3):222-33. PubMed ID: 14649589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psycho-pharmacotherapy for anxiety and obsessive-compulsive disorder: the issue of prolonged barbiturate retention.
    Feldmann RE; Kranz G; Praschak-Rieder N; Kasper S
    Curr Med Res Opin; 2009 Sep; 25(9):2281-5. PubMed ID: 19630487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The epidemiology of psychotropic drug use in children and adolescents.
    Bonati M; Clavenna A
    Int Rev Psychiatry; 2005 Jun; 17(3):181-8. PubMed ID: 16194789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Psychopharmacotherapy of anxiety, obsessive-compulsive and sleep disorders during pregnancy and lactation].
    Szajer K; KarakuĊ‚a H; Pawezka J; Grzywa A; Przywara G; Gut A
    Psychiatr Pol; 2005; 39(3):519-26. PubMed ID: 16149761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychotropic agents in dermatology.
    Koo JY
    Dermatol Clin; 1993 Jan; 11(1):215-24. PubMed ID: 8435914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Obsessive-compulsive disorders].
    Voderholzer U
    Fortschr Neurol Psychiatr; 2005 Sep; 73(9):526-42. PubMed ID: 16155863
    [No Abstract]   [Full Text] [Related]  

  • 20. Resistance to medication during psychoanalysis.
    Roose SP; Gabbard GO
    J Psychother Pract Res; 1997; 6(3):239-48. PubMed ID: 9185069
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.